Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (161-170 of 302) with videos related to

Pageof 31
Sort By:
Journal of Ovarian Research|February 14, 2023
Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Gynecologic Oncology|October 5, 2018
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterAdam C ElNaggar, Erinn M Hade, David M O'Malley, et al.
Gynecologic Oncology Reports|June 20, 2022
Ridiculously good writing: How to write like a pro and publish like a bossSusan C Modesitt, Laura J Havrilesky, Rebecca A Previs, et al.
Gynecologic Oncology|April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessmentCasey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Oncotarget|October 6, 2017
Novel <i>SOX17</i> frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutationsChristopher J Walker, Matthew J O'Hern, Vanida A Serna, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 14, 2015
The Use of Transvaginal Ultrasound in Type II Endometrial CancerCaroline C Billingsley, Kimberly A Kenne, Catherine D Cansino, et al.
Gynecologic Oncology|June 12, 2009
Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancerFloor J Backes, Marino E Leon, Iouri Ivanov, et al.
Gynecologic Oncology|November 17, 2012
Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgeryLorna A Brudie, Floor J Backes, Sarfraz Ahmad, et al.
Frontiers in Immunology|November 8, 2023
Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imagingDavid E Cohn, Aisling Forder, Erin A Marshall, et al.
Gynecologic Oncology|August 1, 2017
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyDavid E Cohn, Michael W Sill, Joan L Walker, et al.
Pageof 31

Showing results (161-170 of 302) with videos related to

Sort By:
Pageof 31
Journal of Ovarian Research|February 14, 2023
Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Gynecologic Oncology|October 5, 2018
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterAdam C ElNaggar, Erinn M Hade, David M O'Malley, et al.
Gynecologic Oncology Reports|June 20, 2022
Ridiculously good writing: How to write like a pro and publish like a bossSusan C Modesitt, Laura J Havrilesky, Rebecca A Previs, et al.
Gynecologic Oncology|April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessmentCasey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Oncotarget|October 6, 2017
Novel <i>SOX17</i> frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutationsChristopher J Walker, Matthew J O'Hern, Vanida A Serna, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 14, 2015
The Use of Transvaginal Ultrasound in Type II Endometrial CancerCaroline C Billingsley, Kimberly A Kenne, Catherine D Cansino, et al.
Gynecologic Oncology|June 12, 2009
Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancerFloor J Backes, Marino E Leon, Iouri Ivanov, et al.
Gynecologic Oncology|November 17, 2012
Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgeryLorna A Brudie, Floor J Backes, Sarfraz Ahmad, et al.
Frontiers in Immunology|November 8, 2023
Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imagingDavid E Cohn, Aisling Forder, Erin A Marshall, et al.
Gynecologic Oncology|August 1, 2017
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyDavid E Cohn, Michael W Sill, Joan L Walker, et al.
Pageof 31